Delivery Order SPE2DE24D0013-SPE2D625F0NNM
- Not listed
- The U.S. Defense Health Agency, through the Medical Supply Chain, awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 12, 2025, for molecular diagnostic solutions with an ultimate completion date of August 19, 2025. This delivery order, designated 4569068770 and titled XPCOV2/FLU/RSV-10, leverages Cepheid's expertise in infectious disease diagnostics and carries no set-aside designation. The work will be performed at Cepheid's facility in Sunnyvale,...
- The Defense Department's Medical Supply Chain awarded a $57.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on September 8, 2025, for molecular diagnostic solutions with an ultimate completion date of September 15, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, will be performed in Sunnyvale, California, where Cepheid manufactures its GeneXpert diagnostic systems and associated test kits. This award carries no set-aside designation and represents a continuation of...
- The U.S. Defense Medical Supply Chain awarded a firm fixed-price delivery order valued at $10,200 to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 15, 2025, with completion scheduled for August 22, 2025. The delivery order, designated 4569128836 for XPCOV2/FLU/RSV-10 diagnostic solutions, carries no set-aside designation and will be performed at Cepheid's Sunnyvale, California facility. This award represents procurement of molecular diagnostic testing capabilities, specifically for detection of...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $40.8K firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The award, issued on July 30, 2025, with an ultimate completion date of August 6, 2025, carries no set-aside designation and covers diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. Performance will take place at...
- The U.S. Defense Department's Medical Supply Chain division awarded a $19,375 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order (XPRS4PLEX-10) represents a continuation of the federal government's ongoing procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. The award carries no set-aside designation and is likely issued under one of Cepheid's existing...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $12,694.80 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on September 9, 2025, for molecular diagnostic testing solutions. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 16, 2025, and will be performed at Cepheid's Sunnyvale, California facility. This award carries no set-aside designation and represents a routine procurement under the company's existing...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,815.72 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on June 27, 2025, for completion by July 7, 2025. The delivery order, identified as XPRSMVP-10, will be performed in Sunnyvale, California, and carries no set-aside designation. Cepheid, a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, specializes in advanced diagnostic systems and test kits for infectious diseases, genetic...
- The U.S. Department of Defense Medical Supply Chain awarded a $2,117.50 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on September 11, 2025, for SARS-COV-2+ testing supplies. The contract, with an ultimate completion date of September 25, 2025, will be performed in Sunnyvale, California, where Cepheid maintains its headquarters. This delivery order was issued without a set-aside designation, reflecting open and competitive procurement practices. The award represents...
- The U.S. Defense Department's Medical Supply Chain organization awarded a $2,024 firm fixed-price delivery order to Cepheid Inc. on August 7, 2025, with an ultimate completion date of August 14, 2025. The delivery order, designated XPRSTREPA-10, was issued without a set-aside designation to the Sunnyvale, California-based molecular diagnostics manufacturer. This delivery order represents a continuation of Cepheid's longstanding federal contract relationship, drawing from the company's existing...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on August 11, 2025, with an ultimate completion date of August 18, 2025, pertains to XPCOV2/FLU/RSV-10 testing capabilities and carries no set-aside designation. The contract represents work performed under Cepheid's larger indefinite delivery vehicles,...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F0NNMDelivery Order
On August 8, 2025, the Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a firm fixed-price delivery order valued at $10,200 to Cepheid Inc. (UEI: W6HQTMWB9Q28) for molecular diagnostic solutions. The delivery order, identified as XPRS4PLEX-10 with contract number 4569031069, requires completion by August 15, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. This award carries no set-aside designation and represents a continuation of the Department of Defense's procurement of diagnostic testing capabilities from the established vendor. Cepheid specializes in advanced molecular diagnostic systems and test kits for infectious diseases and clinical testing, with a demonstrated track record of supporting federal healthcare agencies through multiple delivery orders and indefinite delivery vehicle contracts. The company maintains significant IDV agreements with the Veterans Health Administration valued at over $35 million combined, providing PCR testing systems, reagents, and assays for conditions including COVID-19, influenza, RSV, and tuberculosis. This delivery order aligns with the Department of Defense's broader medical supply chain requirements and leverages Cepheid's existing infrastructure and capabilities to support diagnostic testing needs across the defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 8/8/25 |